Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hemodynamic predictors of antihypertensive drug response in essential hypertension
2006-006981-40Phase 4Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust jointly with University of Cambridge
- Start
- Apr 2007
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of doxazosin, bisoprolol, candesartan and isosorbide mononitrate in essential hypertension (4 arms), sponsored by Cambridge University Hospitals NHS Foundation Trust jointly with University of Cambridge. Started Apr 2007; status: completed.
02
Drugs
doxazosinbisoprololcandesartanisosorbide mononitrate
03
Conditions
essential hypertension
Beyond the preview
Go deeper on 2006-006981-40.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-006981-40.